Marubeni's Strategic Goals and Growth Drivers - Marubeni aims to exceed ¥10 trillion in market capitalization by FYE 3/2031[6] - The company's core operating cash flow (COCF) grew at a CAGR of 11% between FYE 3/2020 and FYE 3/2025, driven by natural resources (14% CAGR) and strategic platform businesses (16% CAGR)[8] - Marubeni targets a non-resources ROIC of 10% or more by FYE 3/2031 through strategic capital allocation and divestments[27] - The company plans to allocate ¥1.7 trillion to new investments, CAPEX, and other areas during GC2027, with ¥1.2 trillion specifically for strategic platform businesses[19] Strategic Platform Businesses Expansion - Agri-inputs retail businesses' combined net profit has grown at a CAGR of 93% over the past decade[38] - The mobility business in North America targets a 20% CAGR in net profit, aiming for ¥56 billion by FYE 3/2028[82] - Wholesale and retail power trading business has experienced a net profit CAGR of 24% and a core operating cash flow CAGR of 27% over the past decade[92] - Marubeni Pharmaceuticals aims for ¥100+ billion in revenue and ¥20+ billion in profit by FYE 3/2031[135] Capital Allocation and Shareholder Returns - Marubeni plans to allocate ¥700 billion for shareholder distributions during GC2027[19] - The company's total payout to shareholders has increased at a CAGR of 31% from FYE 3/2020 to FYE 3/2025[32]